During the past decade, Kerrville Allergy and Asthma Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kerrville Allergy and Asthma Associates" are "Asthma" (1 trials) and "Rhinitis, Allergic, Seasonal" (1 trials). Many other conditions were trialed in "Kerrville Allergy and Asthma Associates" in a lesser frequency.

Most popular intervention types in "Kerrville Allergy and Asthma Associates" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amb a 1 immunostimulatory oligodeoxyribonucleotide conjugate" (1 trials), "HFA placebo" (1 trials), "Histamine base" (1 trials), "albuterol HFA (Armstrong's)" (1 trials) and "albuterol HFA (Proventil HFA)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kerrville Allergy and Asthma Associates" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kerrville Allergy and Asthma Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Kerrville Allergy and Asthma Associates, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Kerrville Allergy and Asthma Associates, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".